NEW YORK, Sept. 11 (GenomeWeb News) - Microfluidics company Eksigent Technologies won a $2 million grant from the National Institute of Standards and Technology's Advanced Technology Program, the firm said today.
The grant will help fund the company's ChipLC system, which is being designed to enable researchers to use high performance liquid chromatography and perform highly parallel chip-based chemical analysis.
The ATP funding will be used for a 3-year development program. Eksigent expects to commercialize intermediate-stage chip-based products during the three years.